Delivra Health Brands Inc
Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancou… Read more
Delivra Health Brands Inc (DHBUF) - Net Assets
Latest net assets as of September 2025: $4.33 Million USD
Based on the latest financial reports, Delivra Health Brands Inc (DHBUF) has net assets worth $4.33 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.09 Million) and total liabilities ($4.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.33 Million |
| % of Total Assets | 47.61% |
| Annual Growth Rate | -43.85% |
| 5-Year Change | -85.8% |
| 10-Year Change | N/A |
| Growth Volatility | 48.86 |
Delivra Health Brands Inc - Net Assets Trend (2019–2024)
This chart illustrates how Delivra Health Brands Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Delivra Health Brands Inc (2019–2024)
The table below shows the annual net assets of Delivra Health Brands Inc from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $5.19 Million | +53.26% |
| 2023-06-30 | $3.39 Million | +0.47% |
| 2022-06-30 | $3.37 Million | -66.19% |
| 2021-06-30 | $9.98 Million | -72.72% |
| 2020-06-30 | $36.57 Million | -60.73% |
| 2019-06-30 | $93.14 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Delivra Health Brands Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11471200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $174.36 Million | 3356.87% |
| Total Equity | $5.19 Million | 100.00% |
Delivra Health Brands Inc Competitors by Market Cap
The table below lists competitors of Delivra Health Brands Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EATON CORP -NPV-
MU:3EC
|
$2.91 Million |
|
Firstwave Cloud Technology Ltd
AU:FCT
|
$2.91 Million |
|
CPI Computer Peripherals International
AT:CPI
|
$2.91 Million |
|
Infinity Lithium Corporation Ltd
AU:INF
|
$2.92 Million |
|
Loyal Textile Mills Limited
NSE:LOYALTEX
|
$2.91 Million |
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
$2.91 Million |
|
INVO Bioscience Inc
NASDAQ:INVO
|
$2.91 Million |
|
Joy Industrial Co., Ltd.
TWO:4559
|
$2.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Delivra Health Brands Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,389,000 to 5,194,000, a change of 1,805,000 (53.3%).
- Net income of 876,000 contributed positively to equity growth.
- New share issuances of 819,000 increased equity.
- Other factors increased equity by 110,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $876.00K | +16.87% |
| Share Issuances | $819.00K | +15.77% |
| Other Changes | $110.00K | +2.12% |
| Total Change | $- | 53.26% |
Book Value vs Market Value Analysis
This analysis compares Delivra Health Brands Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.74x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.26x to 0.74x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-06-30 | $0.48 | $0.12 | x |
| 2020-06-30 | $0.16 | $0.12 | x |
| 2021-06-30 | $0.04 | $0.12 | x |
| 2022-06-30 | $0.01 | $0.12 | x |
| 2023-06-30 | $0.01 | $0.12 | x |
| 2024-06-30 | $0.17 | $0.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Delivra Health Brands Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.87%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.08%
- • Asset Turnover: 1.23x
- • Equity Multiplier: 1.94x
- Recent ROE (16.87%) is above the historical average (-125.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -31.45% | -242.93% | 0.11x | 1.16x | $-36.71 Million |
| 2020 | -238.26% | -952.49% | 0.14x | 1.73x | $-83.21 Million |
| 2021 | -286.04% | -358.70% | 0.42x | 1.91x | $-29.54 Million |
| 2022 | -207.80% | -86.12% | 0.70x | 3.43x | $-7.35 Million |
| 2023 | -5.43% | -1.88% | 0.93x | 3.12x | $-522.90K |
| 2024 | 16.87% | 7.08% | 1.23x | 1.94x | $356.60K |
Industry Comparison
This section compares Delivra Health Brands Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Delivra Health Brands Inc (DHBUF) | $4.33 Million | -31.45% | 1.10x | $2.91 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |